Cell Reports (Dec 2018)

Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells

  • Giusy Tornillo,
  • Catherine Knowlson,
  • Howard Kendrick,
  • Joe Cooke,
  • Hasan Mirza,
  • Iskander Aurrekoetxea-Rodríguez,
  • Maria d.M. Vivanco,
  • Niamh E. Buckley,
  • Anita Grigoriadis,
  • Matthew J. Smalley

Journal volume & issue
Vol. 25, no. 13
pp. 3674 – 3692.e10

Abstract

Read online

Summary: The SRC-family kinase LYN is highly expressed in triple-negative/basal-like breast cancer (TNBC) and in the cell of origin of these tumors, c-KIT-positive luminal progenitors. Here, we demonstrate LYN is a downstream effector of c-KIT in normal mammary cells and protective of apoptosis upon genotoxic stress. LYN activity is modulated by PIN1, a prolyl isomerase, and in BRCA1 mutant TNBC PIN1 upregulation activates LYN independently of c-KIT. Furthermore, the full-length LYN splice isoform (as opposed to the Δaa25–45 variant) drives migration and invasion of aggressive TNBC cells, while the ratio of splice variants is informative for breast cancer-specific survival across all breast cancers. Thus, dual mechanisms—uncoupling from upstream signals and splice isoform ratios—drive the activity of LYN in aggressive breast cancers. : Tornillo et al. show that in aggressive breast cancers, LYN activity is deregulated by a change in patterns of splice isoform expression. In BRCA1-dysfunctional breast cancers, LYN activity is upregulated by a prolyl isomerase (PIN1) that is normally repressed by BRCA1. Keywords: BRCA1, LYN kinase, triple-negative/basal-like breast cancer, PIN1, ESRP1, c-KIT